| 1 |
34289657 | Complement dysregulation is associated with severe COVID-19 illness. | 2022 May 1 |
1 |
| 2 |
34929169 | The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. | 2022 Feb |
5 |
| 3 |
35060381 | Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II. | 2022 Feb 14 |
2 |
| 4 |
35169535 | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. | 2022 Feb 11 |
1 |
| 5 |
35194375 | In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface. | 2022 Apr |
1 |
| 6 |
35215371 | Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate. | 2022 Feb 21 |
2 |
| 7 |
33357843 | Comprehensive Landscape of Heparin Therapy for COVID-19. | 2021 Feb 15 |
2 |
| 8 |
33789211 | SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. | 2021 May 21 |
2 |
| 9 |
33915212 | Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. | 2021 Jul 31 |
3 |
| 10 |
33968333 | Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain. | 2021 |
1 |
| 11 |
33968948 | The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19. | 2021 |
1 |
| 12 |
34200372 | ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. | 2021 Jun 7 |
4 |
| 13 |
34235261 | Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2. | 2021 Jun 23 |
1 |
| 14 |
34537241 | Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection. | 2021 Oct |
1 |
| 15 |
34743814 | SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. | 2021 Dec 15 |
1 |
| 16 |
34940684 | Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from Monostroma nitidum. | 2021 Nov 30 |
1 |
| 17 |
32699853 | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. | 2020 Jul 14 |
8 |
| 18 |
32970989 | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. | 2020 Nov 12 |
5 |
| 19 |
33298900 | Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. | 2020 Nov 4 |
2 |
| 20 |
33368089 | Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin. | 2020 Dec |
4 |